₹ 1,377.00
-8.00 (-0.58%)
D
Dr Reddys Laboratories
₹ 1,377.00
Dr Reddys Laboratories EPS Summary (consolidated)
The latest quarterly EPS of Dr Reddys Laboratories as of Q2 Sep 2026 stands at ₹11.10. This is a 108.26% growth quarter on quarter and 31.40% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹9.04. It beat the estimate by ₹2.06. For the FY2026 the EPS of Dr Reddys Laboratories stands at ₹50.41. This is a 25.75% fall compared with FY2025.
Dr Reddys Laboratories EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

